Broth microdilution testing of susceptibilities to 30 antimicrobial agents of Mycobacterium avium strains from patients with acquired immune deficiency syndrome
- 1 October 1987
- journal article
- research article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 31 (10) , 1579-1584
- https://doi.org/10.1128/aac.31.10.1579
Abstract
A total of 31 strains of Mycobacterium avium complex isolated from patients with acquired immune deficiency syndrome were tested for susceptibility to 30 antimicrobial agents by using microdilution trays containing dried antimicrobial agents. MICs were determined over a period of 7 days of growth in a broth medium (7HSF) that is equivalent to 7H11 agar. MICs obtained by this method showed good agreement with MICs determined by the agar dilution method. Strains could be divided into two groups by their antimicrobial susceptibility patterns. All group 1 strains (8 of the 31 strains tested) were at least moderately susceptible to inhibition by a variety of beta-lactam antimicrobial agents, including amoxicillin-clavulanic acid and cefmenoxime. Group 2 strains (23 of 31) were susceptible only to amikacin (22 of 23 strains). All 31 strains were resistant to oxacillin, clindamycin, erythromycin, tetracycline, chloramphenicol, vancomycin, nitrofurantoin, and aztreonam at the highest concentration of antimicrobial agent present in the microdilution trays. The addition of Tween 80 to 7HSF broth increased the susceptibility of M. avium complex to many of the antimicrobial agents tested. Killing of M. avium complex (i.e., less than or equal to 1% survival after 7 days) was found to vary for different strains and antimicrobial agents. Killing of some strains by amoxicillin-clavulanic acid, carbenicillin, azlocillin, cefmenoxime, cefotaxime, amikacin, and ampicillin occurred at concentrations of antimicrobial agent that are achievable in serum. Further studies are needed to determine whether any of these antimicrobial agents has activity against M. avium complex cells that have been ingested by macrophages.This publication has 18 references indexed in Scilit:
- Therapeutic implications of inhibition versus killing of Mycobacterium avium complex by antimicrobial agentsAntimicrobial Agents and Chemotherapy, 1987
- Effect of Combined Clofazimine and Ansamycin Therapy on Mycobacterium avium--Mycobacterium intracellulare Bacteremia in Patients with AIDSThe Journal of Infectious Diseases, 1987
- Comparative in vitro activities of ciprofloxacin and other 4-quinolones against Mycobacterium tuberculosis and Mycobacterium intracellulareAntimicrobial Agents and Chemotherapy, 1986
- Determination of ansamycin MICs for Mycobacterium avium complex in liquid medium by radiometric and conventional methodsAntimicrobial Agents and Chemotherapy, 1985
- Comparative in vitro activities of MDL 473, rifampin, and ansamycin against Mycobacterium intracellulareAntimicrobial Agents and Chemotherapy, 1985
- Morphological changes induced by beta-lactam antibiotics in Mycobacterium avium-intracellulare complexAntimicrobial Agents and Chemotherapy, 1985
- Susceptibility of intra- and extracellular Mycobacterium avium-intracellulare to cephem antibioticsAntimicrobial Agents and Chemotherapy, 1985
- Intra- and extracellular susceptibility of Mycobacterium avium-intracellulare complex to aminoglycoside antibioticsAntimicrobial Agents and Chemotherapy, 1984
- Basis for Lack of Drug Susceptibility of Atypical MycobacteriaClinical Infectious Diseases, 1981
- Permeability Barrier to Rifampin in MycobacteriaAntimicrobial Agents and Chemotherapy, 1977